RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
44.81
-0.31 (-0.69%)
Nov 20, 2024, 4:00 PM EST - Market open
RxSight Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Revenue | 128.29 | 89.08 | 49.01 | 22.59 | 14.68 | 2.24 | Upgrade
|
Revenue Growth (YoY) | 67.52% | 81.77% | 116.90% | 53.92% | 554.98% | 284.09% | Upgrade
|
Cost of Revenue | 40.48 | 35.31 | 27.68 | 18.08 | 12.97 | 4.06 | Upgrade
|
Gross Profit | 87.81 | 53.77 | 21.33 | 4.52 | 1.71 | -1.82 | Upgrade
|
Selling, General & Admin | 94.48 | 74.9 | 58.99 | 33.1 | 15.36 | 15.21 | Upgrade
|
Research & Development | 32.41 | 28.95 | 25.66 | 24.2 | 21.75 | 29.57 | Upgrade
|
Operating Expenses | 126.89 | 103.85 | 84.65 | 57.3 | 37.11 | 44.77 | Upgrade
|
Operating Income | -39.08 | -50.09 | -63.32 | -52.79 | -35.41 | -46.59 | Upgrade
|
Interest Expense | -0.02 | -3.31 | -4.95 | -3.68 | -0.51 | -0.03 | Upgrade
|
Interest & Investment Income | 8.43 | 6.57 | 1.52 | 0.05 | 0.54 | 2.31 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | - | 7.74 | 63.01 | 170.03 | Upgrade
|
EBT Excluding Unusual Items | -30.67 | -46.82 | -66.75 | -48.68 | 27.64 | 125.72 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | -0.01 | 0.52 | Upgrade
|
Other Unusual Items | - | -1.77 | - | - | - | - | Upgrade
|
Pretax Income | -30.67 | -48.59 | -66.75 | -48.68 | 27.63 | 126.24 | Upgrade
|
Income Tax Expense | 0.02 | 0.02 | 0.01 | 0.01 | 0.06 | 0.02 | Upgrade
|
Earnings From Continuing Operations | - | -48.61 | -66.76 | -48.69 | 27.58 | 126.22 | Upgrade
|
Net Income | -30.69 | -48.61 | -66.76 | -48.69 | 27.58 | 126.22 | Upgrade
|
Preferred Dividends & Other Adjustments | - | - | - | - | 24.21 | 100.09 | Upgrade
|
Net Income to Common | -30.69 | -48.61 | -66.76 | -48.69 | 3.37 | 26.13 | Upgrade
|
Net Income Growth | - | - | - | - | -78.15% | - | Upgrade
|
Shares Outstanding (Basic) | 38 | 34 | 28 | 14 | 4 | 3 | Upgrade
|
Shares Outstanding (Diluted) | 38 | 34 | 28 | 14 | 6 | 21 | Upgrade
|
Shares Change (YoY) | 16.36% | 24.56% | 103.02% | 146.28% | -73.12% | - | Upgrade
|
EPS (Basic) | -0.81 | -1.41 | -2.41 | -3.57 | 0.91 | 7.62 | Upgrade
|
EPS (Diluted) | -0.81 | -1.41 | -2.41 | -3.57 | 0.15 | 6.00 | Upgrade
|
EPS Growth | - | - | - | - | -97.42% | - | Upgrade
|
Free Cash Flow | -27.17 | -46.41 | -61.24 | -46.65 | -37.74 | -44.71 | Upgrade
|
Free Cash Flow Per Share | -0.72 | -1.35 | -2.21 | -3.42 | -6.82 | -2.17 | Upgrade
|
Gross Margin | 68.44% | 60.36% | 43.52% | 19.99% | 11.62% | -81.17% | Upgrade
|
Operating Margin | -30.46% | -56.23% | -129.21% | -233.64% | -241.21% | -2079.03% | Upgrade
|
Profit Margin | -23.92% | -54.57% | -136.22% | -215.50% | 22.93% | 1165.86% | Upgrade
|
Free Cash Flow Margin | -21.18% | -52.10% | -124.97% | -206.47% | -257.13% | -1994.87% | Upgrade
|
EBITDA | -34.97 | -46.01 | -59.43 | -48.81 | -31.55 | -42.83 | Upgrade
|
EBITDA Margin | -27.26% | -51.65% | -121.28% | -216.05% | -214.96% | - | Upgrade
|
D&A For EBITDA | 4.11 | 4.08 | 3.88 | 3.98 | 3.85 | 3.76 | Upgrade
|
EBIT | -39.08 | -50.09 | -63.32 | -52.79 | -35.41 | -46.59 | Upgrade
|
EBIT Margin | -30.46% | -56.23% | -129.21% | -233.64% | -241.21% | - | Upgrade
|
Effective Tax Rate | - | - | - | - | 0.21% | 0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.